Johan M. Spoor - Net Worth and Insider Trading

Johan M. Spoor Net Worth

The estimated net worth of Johan M. Spoor is at least $1 Million dollars as of 2024-12-01. Johan M. Spoor is the CEO of Perspective Therapeutics Inc and owns about 234,072 shares of Perspective Therapeutics Inc (CATX) stock worth over $1 Million. Johan M. Spoor is the PRESIDENT AND CEO of Entero Therapeutics Inc and owns about 63 shares of Entero Therapeutics Inc (ENTO) stock worth over $30. Johan M. Spoor is also the CEO, PRESIDENT, CHAIRMAN of FluoroPharma Medical Inc and owns about 200,398 shares of FluoroPharma Medical Inc (FPMI) stock worth over $20. Details can be seen in Johan M. Spoor's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Johan M. Spoor has not made any transactions after 2024-11-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Johan M. Spoor

To

Johan M. Spoor Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Johan M. Spoor owns 5 companies in total, including Entero Therapeutics Inc (ENTO) , MetaStat Inc (MTST) , and FluoroPharma Medical Inc (FPMI) among others .

Click here to see the complete history of Johan M. Spoor’s form 4 insider trades.

Insider Ownership Summary of Johan M. Spoor

Ticker Comapny Transaction Date Type of Owner
ENTO Entero Therapeutics Inc 2018-12-28 director & President and CEO
MTST MetaStat Inc 2014-12-31 director
FPMI FluoroPharma Medical Inc 2014-01-07 director & CEO & PRESIDENT & CHAIRMAN
LIMIT LIMIT 2013-02-15 director
LIMIT LIMIT 2024-06-13 director & CEO

Johan M. Spoor Latest Holdings Summary

Johan M. Spoor currently owns a total of 3 stocks. Among these stocks, Johan M. Spoor owns 234,072 shares of Perspective Therapeutics Inc (CATX) as of November 25, 2024, with a value of $1 Million and a weighting of 100%. Johan M. Spoor owns 63 shares of Entero Therapeutics Inc (ENTO) as of December 28, 2018, with a value of $30 and a weighting of 0%. Johan M. Spoor also owns 200,398 shares of FluoroPharma Medical Inc (FPMI) as of January 7, 2014, with a value of $20 and a weighting of 0%.

Latest Holdings of Johan M. Spoor

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CATX Perspective Therapeutics Inc 2024-11-25 234,072 4.35 1,018,213
ENTO Entero Therapeutics Inc 2018-12-28 63 0.47 30
FPMI FluoroPharma Medical Inc 2014-01-07 200,398 0.00 20

Holding Weightings of Johan M. Spoor


Johan M. Spoor Form 4 Trading Tracker

According to the SEC Form 4 filings, Johan M. Spoor has made a total of 2 transactions in Perspective Therapeutics Inc (CATX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Perspective Therapeutics Inc is the acquisition of 26,500 shares on November 25, 2024, which cost Johan M. Spoor around $100,435.

According to the SEC Form 4 filings, Johan M. Spoor has made a total of 0 transactions in Entero Therapeutics Inc (ENTO) over the past 5 years. The most-recent trade in Entero Therapeutics Inc is the acquisition of 6 shares on December 28, 2018, which cost Johan M. Spoor around $50,158.

According to the SEC Form 4 filings, Johan M. Spoor has made a total of 0 transactions in FluoroPharma Medical Inc (FPMI) over the past 5 years. The most-recent trade in FluoroPharma Medical Inc is the acquisition of 10,000 shares on January 7, 2014, which cost Johan M. Spoor around $5,000.

Insider Trading History of Johan M. Spoor

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Johan M. Spoor Trading Performance

GuruFocus tracks the stock performance after each of Johan M. Spoor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Johan M. Spoor is 19.37%. GuruFocus also compares Johan M. Spoor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Johan M. Spoor within 3 months outperforms 5 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Johan M. Spoor's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Johan M. Spoor

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.59 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.29 LIMIT LIMIT LIMIT LIMIT LIMIT

Johan M. Spoor Ownership Network

Ownership Network List of Johan M. Spoor

No Data

Ownership Network Relation of Johan M. Spoor

Insider Network Chart

Johan M. Spoor Owned Company Details

What does Entero Therapeutics Inc do?

Who are the key executives at Entero Therapeutics Inc?

Johan M. Spoor is the director & President and CEO of Entero Therapeutics Inc. Other key executives at Entero Therapeutics Inc include Chief Financial Officer Sarah Romano , director & President and CEO James Sapirstein , and CHIEF FINANCIAL OFFICER Daniel H Schneiderman .

Entero Therapeutics Inc (ENTO) Insider Trades Summary

Over the past 18 months, Johan M. Spoor made no insider transaction in Entero Therapeutics Inc (ENTO). Other recent insider transactions involving Entero Therapeutics Inc (ENTO) include a net sale of 4,066 shares made by Sarah Romano , a net sale of 6,280 shares made by James Sapirstein , and a net sale of 6,063 shares made by Charles J Casamento .

In summary, during the past 3 months, insiders sold 476 shares of Entero Therapeutics Inc (ENTO) in total and bought 0 shares, with a net sale of 476 shares. During the past 18 months, 6,431 shares of Entero Therapeutics Inc (ENTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,431 shares.

Entero Therapeutics Inc (ENTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Entero Therapeutics Inc Insider Transactions

No Available Data

Johan M. Spoor Mailing Address

Above is the net worth, insider trading, and ownership report for Johan M. Spoor. You might contact Johan M. Spoor via mailing address: 500 Boylston Street, Suite 1600, Boston Ma 02116.

Discussions on Johan M. Spoor

No discussions yet.